Amber Watson's profile photo

Amber Watson

Contributor at Medical News Today

Featured in: Favicon medicalnewstoday.com

Articles

  • 6 days ago | medicalnewstoday.com | Amber Watson

    Cefdinir has possible interactions with some other drugs and certain supplements. Examples include birth control pills and certain antacids. Talk with your doctor to avoid potentially harmful effects from cefdinir interactions.

  • 2 weeks ago | medicalnewstoday.com | Amber Watson

    Nexlizet (bempedoic acid/ezetimibe) may not be safe to take while pregnant or breastfeeding. Certain factors, including the risks of not treating your condition, may determine whether you should take the drug during this time. If you may be or can become pregnant, it’s important to consider whether Nexlizet is a safe option for you. It isn’t known whether Nexlizet is safe to take during pregnancy. Experts haven’t studied its effects during pregnancy.

  • 3 weeks ago | medicalnewstoday.com | Amber Watson

    Brukinsa has possible interactions with some other drugs and certain supplements. Examples include warfarin (Jantoven) and ciprofloxacin (Cipro). Talk with your doctor to avoid potentially harmful effects from Brukinsa interactions. Brukinsa is available as an oral capsule. It’s prescribed for the following conditions in adults in certain situations:An interaction occurs when one substance causes another substance to have a different effect than expected.

  • 3 weeks ago | medicalnewstoday.com | Amber Watson

    Simponi (golimumab) is a brand-name subcutaneous injection that’s prescribed for ulcerative colitis. This article covers topics such as side effects, dosage, and how Simponi works. Simponi is a biologic and belongs to a drug class called tumor necrosis factor (TNF) blockers. The medication is not available in a biosimilar version. Read on for more information about Simponi. You can also refer to this other article for a comprehensive look at Simponi and its other uses. Simponi has boxed warnings.

  • 4 weeks ago | medicalnewstoday.com | Amber Watson

    Nucala (mepolizumab) and Dupixent (dupilumab) are brand-name subcutaneous injections. They’re both prescribed for asthma and chronic rhinosinusitis with nasal polyps. Each drug may also be prescribed for other uses. This article explains the main similarities and differences between Nucala and Dupixent. If you’re considering treatment with one of these drugs, discussing this information with your doctor can help you decide if one of these drugs may be right for you.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →